DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR FENTANYL CITRATE
All Clinical Trials for Fentanyl Citrate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00105287 | Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients | Completed | Cephalon | Phase 3 | 2005-01-01 | The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients. |
| NCT00105937 | OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients | Completed | Cephalon | Phase 3 | 2004-04-01 | The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant. |
| NCT00125801 | The Pain Pen for Breakthrough Cancer Pain | Terminated | Erasmus Medical Center | Phase 3 | 2005-08-01 | The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine. |
| NCT00209534 | A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy | Completed | Bio Analytical Research Corporation | Phase 2 | 2003-01-01 | This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients received fentanyl citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation. Throughout the procedure, study personnel assessed the patient's vital signs and depth of sedation. After the procedure, the patient, physician, and an evaluator were asked to complete satisfaction surveys. |
| NCT00209534 | A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy | Completed | HHI Clinical Research (Biostatistics) | Phase 2 | 2003-01-01 | This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients received fentanyl citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation. Throughout the procedure, study personnel assessed the patient's vital signs and depth of sedation. After the procedure, the patient, physician, and an evaluator were asked to complete satisfaction surveys. |
| NCT00209534 | A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy | Completed | MDS Pharma Services | Phase 2 | 2003-01-01 | This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients received fentanyl citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation. Throughout the procedure, study personnel assessed the patient's vital signs and depth of sedation. After the procedure, the patient, physician, and an evaluator were asked to complete satisfaction surveys. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Fentanyl Citrate
Condition Name
Clinical Trial Locations for Fentanyl Citrate
Trials by Country
Clinical Trial Progress for Fentanyl Citrate
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Fentanyl Citrate
Sponsor Name
